A randomized controlled multicenter clinical trial of Xinxinfu combined with Qiangxin Fang in the treatment of coronary heart disease complicated with cardiac insufficiency

Not Applicable

• Conditions: Coronary heart disease

• Registration Number: ITMCTR2000003805
• Lead Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) those who meet the diagnostic criteria of coronary heart disease, chronic heart failure and Yang deficiency and Blood Stasis Syndrome of TCM;
(2) those aged 18 to 75;
(3) those who have not taken any other proprietary Chinese medicine or decoction for treating coronary heart disease with heart failure within 2 weeks;
(4) the patient informed and consented to the study and has signed the informed consent form, in line with our hospital ethics committee certification, all treatment and examination are informed consent of patients or family members.

Exclusion Criteria

(1) with Cardiogenic shock, severe ventricular Arrhythmia, complete atrioventricular block, obstructive cardiomyopathy, severe valvular heart disease, severe pericardial disease;
(2) allergic to or allergic to multiple drugs;
(3) suffering from serious diseases such as liver, kidney, brain, blood system and infection;
(4) non-cooperative patient or patient with mental disease;
(5) hypertension, diabetes not under control or unstable control;
(6) inability to work with researchers due to disability or mental illness.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessment of cardiac function;Assessment of cardiac function;Pulmonary function assessment;